Free shipping on all orders over $ 500

NXY-059

Cat. No. M1868

All AbMole products are for research use only, cannot be used for human consumption.

NXY-059 Structure
Synonym:

Disufenton sodium, Cerovive

Size Price Availability Quantity
5mg USD 48  USD48 In stock
10mg USD 74  USD74 In stock
25mg USD 160  USD160 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

NXY-059 is a free radical-trapping neuroprotectant that has been reported to reduce infarct size and preserve brain function in experimental models of acute ischemic stroke. NXY-059-treated animals significantly reduced the loss of hemispheric tissue compared to brain-injured controls (43.0 +/- 11 mm3 versus 74.4 +/- 19 mm3, respectively; p < 0.01). NXY-059 significantly attenuated the loss of injured brain tissue and improved cognitive outcome, suggesting a major role for ROS in the pathophysiology of TBI. NXY-059 is now under the Phase 2 clinical trial in patients with prelapsed or refractory multiple myeloma.

Protocol (for reference only)
Cell Experiment
Cell lines
Preparation method
Concentrations
Incubation time
Animal Experiment
Animal models transient focal cerebral ischemia in the rat model
Formulation normal saline
Dosages 0.3, 3 or 30 mg/kg
Administration i.v.
Chemical Information
Molecular Weight 381.33
Formula C11H13NNa2O7S2
CAS Number 168021-79-2
Solubility (25°C) DMSO ≥60 mg/mL
Water ≥60 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Culot et al. Brain Res. Cerebrovascular protection as a possible mechanism for the protective effects of NXY-059 in preclinical models: an in vitro study.

[2] Bath et al. Br J Pharmacol. Effects of NXY-059 in experimental stroke: an individual animal meta-analysis.

[3] Clausen et al. J Neurotrauma. The nitrone free radical scavenger NXY-059 is neuroprotective when administered after traumatic brain injury in the rat.

[4] Dehouck MP, et al. Brain Res. In vitro blood-brain barrier permeability and cerebral endothelial cell uptake of the neuroprotective nitrone compound NXY-059 in normoxic, hypoxic and ischemic conditions.

[5] Kuroda S, et al. J Cereb Blood Flow Metab. Neuroprotective effects of a novel nitrone, NXY-059, after transient focal cerebral ischemia in the rat.

Related Products
DSPE-PEG-FA

DSPE-PEG2K-FA is a PEG derivative containing folic acid. DSPE-PEG2K-FA has a targeting effect and can bind to folic acid receptors in cancer cells. DSPE-PEG2K-FA forms micelles/lipid bilayers and can be used in research on targeted drug delivery systems.

Lifastuzumab

Lifastuzumab is a humanized anti-NaPi2b IgG1 monoclonal antibody.

GPVI antagonist 1

GPVI antagonist 1 is a glycoprotein VI (GPVI) platelet receptor antagonist. GPVI antagonist 1 inhibits collagen-induced platelet aggregation with an IC50 of 25.3 μM.

MPSD TFA

MPSD TFA (MARCKS-ED TFA) is a 25-amino acid peptide based on the effector domain sequence of the intracellular membrane protein myristoylated alanine-rich C-kinase substrate (MARCKS). MPSD TFA can sense membrane curvature and recognize phosphatidylserine. MPSD TFA can be utilized as biological probe to study membrane shape and lipid composition.

4-Nitro-2,1,3-benzoselenadiazole

4-Nitro-2,1,3-benzoselenadiazole is a biochemical material that can be used in scientific research.

  Catalog
Abmole Inhibitor Catalog




Keywords: NXY-059, Disufenton sodium, Cerovive supplier, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.